Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

Carboplatin: uses, dosing, side effects & brands

Carboplatin is a medicine sold in the U.S. under 2 brand and generic names. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable · Solution
Sold as
2 products — Carboplatin and Paraplatin
Prescription?
Prescription only
Generic available?
Yes

Every carboplatin product we track (2)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Carboplatin products
#DrugRatingPharmacy pays
1
Carboplatin
54/100—View →
2
Paraplatin
Not yet rated—View →

How long carboplatin keeps

The date on a sealed pack is not the only one: some carboplatin labels start a second clock once the product is opened or mixed, as short as 8 hours.

The in-use limits carboplatin labels print, quoted

Carboplatin and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

After carboplatin administration to nursing mothers, excretion of platinum into milk occurs. The exact forms and toxicities of platinum excreted into breastmilk are not known. The nursing infant would receive platinum compounds orally rather than intravenously and oral absorption of platinum compounds by infants is not known. Platinum in milk may increase with repeated courses of chemotherapy. Most sources consider that mothers receiving antineoplastic therapy should not breastfeed, especially with alkylating agents such as cisplatin. It is probably not safe to breastfeed during carboplatin therapy, and breastfeeding should be discontinued. Resuming breastfeeding 3 weeks after the last dose of cisplatin has been done safely in one case.

Full LactMed record for carboplatin: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised May 15, 2026. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about carboplatin

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 131,100 reports naming carboplatin, and the FDA flagged 95% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • neutropenia7,705 reports
  • anaemia7,481 reports
  • nausea7,347 reports
  • febrile neutropenia6,826 reports
  • diarrhoea6,484 reports
  • malignant neoplasm progression6,318 reports
  • thrombocytopenia6,166 reports
  • dyspnoea5,796 reports

Read these as a signal, not a rate. A report does not mean carboplatin caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved August 25, 2026.

Related calculators

How long it stays in your system →

Frequently asked questions

Can you take carboplatin with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run carboplatin against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What brand names is carboplatin sold under?

We track 2 carboplatin-containing products in the U.S.: Carboplatin and Paraplatin. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

What forms does carboplatin come in?

Across the brands we track, carboplatin is currently marketed as injectable and solution, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic carboplatin?

Yes. Our catalog lists 1 generic carboplatin product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Cite this page
APA
pharmaranks. (2026, July 24). Carboplatin: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/carboplatin
MLA
“Carboplatin: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/carboplatin.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for carboplatin on DailyMed (NIH) ↗.